ATLASATLAS fair value
NOK 314.67
Close to fair value · 3% discount
Range: NOK 225–NOK 439Fair valuePrice
Medistim (MEDI.OL)
Medistim stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Oslo Børs · Norway
NOK 306.00▼ -0.65%
Prices as of Oct 27, 2026 · NOK
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Medistim in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Medistim
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Medistim's fair value at about NOK 314.67 per share (reasonable range: NOK 225.31 to NOK 439.48). At NOK 306.00, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Medistim a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between NOK 288.99 and NOK 324.70; in 9 out of 10, between NOK 260.64 and NOK 360.03. Estimated annual volatility is 31%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- NOK 5.1B
- Market cap (USD)
- $548M
- P/E ratio
- 31.6
- Dividend yield
- 2.67%
- 52-week high
- NOK 316.00
- 52-week low
- NOK 186.50
- Revenue (12 months)
- NOK 796M
- Gross margin
- 81.7%
- Operating margin
- 30.1%
- Net margin
- 22.4%
- Beta
- 0.95
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Medistim sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks MEDI.OL has traded between NOK 186.50 and NOK 316.00. Today it is 3.2% below that high and 64% above its low.
On the business: net margin is 22.4%; it trades at 31.6 times earnings.
Its beta is 0.95: it moves roughly in line with the market.
About the company
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally.
Want to see everything about Medistim?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Medistim (MEDI.OL) fair value?
About NOK 314.67 per share according to ATLAS (reasonable range: NOK 225.31 to NOK 439.48). With the stock at NOK 306.00, it is close to that value.
What is the chance MEDI.OL goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, MEDI.OL ends the month between NOK 288.99 and NOK 324.70.
How big is Medistim and what is its P/E ratio?
Medistim's market capitalization is NOK 5.1B. Its price-to-earnings (P/E) ratio is 31.6: you pay NOK 31.6 for each NOK 1.00 of yearly earnings.
Does Medistim pay a dividend?
Yes. MEDI.OL's current dividend yield is 2.67% at today's price (NOK 306.00).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer